<DOC>
	<DOCNO>NCT00194480</DOCNO>
	<brief_summary>Injection drug use account transmission high proportion Hepatitis C Virus ( HCV ) infection . The purpose trial investigate effectiveness pegylated interferon treat injection drug user ( IDUs ) acute HCV .</brief_summary>
	<brief_title>Treatment Acute Hepatitis C Virus Infection With Pegylated Interferon Injection Drug Users</brief_title>
	<detailed_description>IDUs high risk develop HCV . Pegylated interferon man-made form interferon , chemical naturally produce body work fight virus . Interferon help stop HCV replicating , help immune system kill HCV . The purpose trial determine effectiveness pegylated interferon IDUs HCV . This trial last 24 week . Participants randomly assign one two group . Group 1 receive pegylated interferon group 2 receive active control . Injection either pegylated interferon control occur weekly . During injection visit , participant ask adverse event , include common side effect interferon injection site reaction , headache , myalgia , arthralgia , insomnia , hair loss . At Weeks 2 , 4 , every 4 week thereafter , participant complete depression self-reports . Laboratory assessment occur Week 2 , monthly basis remainder study . Follow-up assessment occur every 4 week Week 24 .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Documented HCV antibody seroconversion within 12 month prior study entry Serum positive HCV Meets hematologic , biochemical , serologic criterion entry visit Thyroid stimulate hormone within normal limit Hepatitis B surface antigen negative Reads eighth grade read level Willing use adequate contraception duration study Plans remain study area 12 month Positive test Hepatitis A antibody , Hepatitis B antibody , HIV antibody Suspected hypersensitivity pegylated interferon Liver disease Hemoglobinopathies Immune mediate disease Significant cardiac pulmonary disease Uncontrolled seizure disorder Renal insufficiency serum creatinine level great 11.5 mb/ml less 60 mb/ml History thyroid disease Active gout Any medical condition require likely require steroid course study Untreated severe psychiatric disorder , determine study psychiatrist Any condition , opinion investigator , would preclude successful completion study Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Hepatitis C , peg-Interferon , drug abuse</keyword>
</DOC>